 |
|
|
| |
Atherosclerotic CVD Risk Profile of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate
|
| |
| |
Reported by Jules Levin
18th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, Sept 12-13, 2016, New York, NY
G Huhn1, D Shamblaw2, JG Baril3, D Baker4, D Ward5, S Guo6, R Haubrich6, T Nguyen-Cleary6, S McCallister6, M Das6
1The Ruth M. Rothstein CORE Center, Chicago, IL, USA; 2La Playa Medical Group and Clinical Research, San Diego, CA, USA; 3Clinique Medicale Du Quartier Latin, Montreal, Canada; 4East Sydney Doctors, Sydney, Australia; 5Dupont Circle Physicians Group, Washington D.C., USA; 6Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
